Zhejiang Wecome Pharmaceutical Company Limited
SZSE:300878.SZ
23.26 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 253.961 | 330.162 | 162.741 | 280.796 | 595.228 | 160.885 | 83.226 | 107.44 | 92.744 | 43.983 | 51.148 | 30.496 |
| Short Term Investments
| 25 | 245.565 | -11.678 | -12.738 | -14.576 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 253.961 | 575.727 | 162.741 | 280.796 | 595.228 | 160.885 | 83.226 | 107.44 | 92.744 | 43.983 | 51.148 | 30.496 |
| Net Receivables
| 217.868 | 276.522 | 333.887 | 409.896 | 299.676 | 212.211 | 159.695 | 114.716 | 0 | 17.346 | 14.325 | 15.492 |
| Inventory
| 118.325 | 153.785 | 116.111 | 129.492 | 82.306 | 60.459 | 73.268 | 74.58 | 47.413 | 39.667 | 19.026 | 15.92 |
| Other Current Assets
| 26.328 | 28.162 | 421.256 | 49.902 | 21.406 | 7.387 | 7.736 | 6.69 | 6.702 | 13.197 | 3.317 | 4.02 |
| Total Current Assets
| 616.482 | 1,034.76 | 899.316 | 870.086 | 998.616 | 440.942 | 323.924 | 303.425 | 178.901 | 114.193 | 87.816 | 65.928 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 853.663 | 857.392 | 895.524 | 706.095 | 548.955 | 368.943 | 245.94 | 125.714 | 95.028 | 95.259 | 81.918 | 36.321 |
| Goodwill
| 10.965 | 27.084 | 27.222 | 17.62 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 33.592 | 35.667 | 37.562 | 39.306 | 30.065 | 30.713 | 28.435 | 28.49 | 28.629 | 2.877 | 2.909 | 2.966 |
| Goodwill and Intangible Assets
| 44.557 | 62.751 | 64.784 | 56.926 | 30.065 | 30.713 | 28.435 | 28.49 | 28.629 | 2.877 | 2.909 | 2.966 |
| Long Term Investments
| 0 | -219.012 | 36.678 | 32.702 | 34.54 | 11.49 | 13.688 | 10.228 | 0 | 0 | 0 | 0 |
| Tax Assets
| 54.665 | 27.07 | 16.521 | 24.594 | 6.117 | 4.932 | 3.817 | 1.251 | 1.836 | 0.112 | 0.095 | 1.39 |
| Other Non-Current Assets
| 82.955 | 283.676 | 0.95 | 2.905 | 10.489 | 18.848 | 25.317 | 10.627 | 10.748 | 9.444 | 0.303 | 0.525 |
| Total Non-Current Assets
| 1,035.841 | 1,011.877 | 1,014.457 | 823.222 | 630.166 | 434.926 | 317.197 | 176.31 | 136.242 | 107.693 | 85.226 | 41.202 |
| Total Assets
| 1,652.323 | 2,046.637 | 1,913.773 | 1,693.308 | 1,628.782 | 875.868 | 641.121 | 479.736 | 315.143 | 221.886 | 173.043 | 107.13 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 78.854 | 101.116 | 65.262 | 33.921 | 114.997 | 74.938 | 56.77 | 55.635 | 30.2 | 32.768 | 31.25 | 22.946 |
| Short Term Debt
| 10.009 | 261.904 | 271.329 | 96.626 | 24.315 | 28.542 | 28.5 | 28.5 | 0 | 0 | 0 | 18 |
| Tax Payables
| 20.35 | 5.438 | 4.245 | 11.4 | 18.724 | 24.349 | 17.239 | 12.741 | 12.37 | 8.969 | 7.99 | 7.259 |
| Deferred Revenue
| 0 | 0 | 46.096 | 71.595 | 82.614 | 80.489 | 86.033 | 69.448 | 0 | 0 | 0 | 15.332 |
| Other Current Liabilities
| 131.169 | 77.093 | 70.525 | 128.633 | 73.596 | 61.844 | 77.939 | -4.535 | 32.654 | 16.701 | 24.281 | -2.327 |
| Total Current Liabilities
| 240.382 | 445.551 | 412.995 | 232.401 | 213.65 | 189.673 | 180.448 | 161.789 | 75.223 | 58.437 | 63.522 | 61.211 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 191.798 | 163.131 | 50.099 | 19.991 | 0 | 136.387 | 41.737 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 38.923 | 42.833 | 32.653 | 25.005 | 26.082 | 27.158 | 23.235 | 11.271 | 12.107 | 9.932 | 9 | 3.57 |
| Deferred Tax Liabilities Non-Current
| 7.396 | 2.033 | 6.507 | 6.887 | 4.662 | 2.807 | 1.871 | 0.621 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 6.507 | 0 | 52.441 | 0 | 0 | 0 | 16.916 | 23.472 | 31.3 | 11.57 |
| Total Non-Current Liabilities
| 238.116 | 207.998 | 89.259 | 51.883 | 30.744 | 166.352 | 66.843 | 11.893 | 29.023 | 33.404 | 31.3 | 11.57 |
| Total Liabilities
| 478.498 | 639.228 | 502.254 | 284.283 | 244.394 | 356.025 | 247.29 | 173.682 | 104.247 | 91.841 | 94.822 | 72.781 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 144.79 | 144.79 | 144.79 | 80.439 | 80.439 | 60.329 | 60.329 | 60.329 | 60.329 | 60.329 | 21.88 | 20 |
| Retained Earnings
| 316.912 | 499.851 | 511.772 | 512.7 | 496.644 | 374.859 | 262.398 | 185.065 | 100.146 | 28.096 | 28.052 | 10.31 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0 | 60.991 | 59.056 | 59.056 | 90.05 | 71.104 | 60.66 | 0 | -0 | 0 | -0 |
| Other Total Stockholders Equity
| 695.964 | 745.96 | 680.765 | 804.172 | 804.172 | -5.394 | 71.104 | 60.66 | 50.421 | 39.631 | 26.32 | 0 |
| Total Shareholders Equity
| 1,157.667 | 1,390.601 | 1,398.318 | 1,397.311 | 1,381.255 | 519.843 | 393.831 | 306.054 | 210.896 | 130.045 | 78.221 | 33.674 |
| Total Equity
| 1,173.825 | 1,408.202 | 1,411.519 | 1,409.025 | 1,384.388 | 519.843 | 393.831 | 306.054 | 210.896 | 130.045 | 78.221 | 34.349 |
| Total Liabilities & Shareholders Equity
| 1,652.323 | 2,046.637 | 1,913.773 | 1,693.308 | 1,628.782 | 875.868 | 641.121 | 479.736 | 315.143 | 221.886 | 173.043 | 107.13 |